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Abstract
Background: Pentasomy X (49,XXXXX) has been associated with a severe clinical condition,
presumably resulting from failure or disruption of X chromosome inactivation. Here we report that
some human X chromosomes from a patient with 49,XXXXX pentasomy were functionally active
following isolation in inter-specific (human-rodent) cell hybrids. A comparison with cytogenetic and
molecular findings provided evidence that more than one active X chromosome was likely to be
present in the cells of this patient, accounting for her abnormal phenotype.
Results: 5-bromodeoxyuridine (BrdU)-pulsed cultures showed different patterns among late
replicating X chromosomes suggesting that their replication was asynchronic and likely to result in
irregular inactivation. Genotyping of the proband and her mother identified four maternal and one
paternal X chromosomes in the proband. It also identified the paternal X chromosome haplotype
(P), indicating that origin of this X pentasomy resulted from two maternal, meiotic non-
disjunctions. Analysis of the HUMANDREC region of the androgen receptor (AR) gene in the
patient's mother showed a skewed inactivation pattern, while a similar analysis in the proband
showed an active paternal X chromosome and preferentially inactivated X chromosomes carrying
the 173 AR allele. Analyses of 33 cell hybrid cell lines selected in medium containing hypoxanthine,
aminopterin and thymidine (HAT) allowed for the identification of three maternal X haplotypes
(M1, M2 and MR) and showed that X chromosomes with the M1, M2 and P haplotypes were
functionally active. In 27 cell hybrids in which more than one X haplotype were detected, analysis
of X inactivation patterns provided evidence of preferential inactivation.
Conclusion: Our findings indicated that 12% of X chromosomes with the M1 haplotype, 43.5% of
X chromosomes with the M2 haplotype, and 100% of the paternal X chromosome (with the P
haplotype) were likely to be functionally active in the proband's cells, a finding indicating that
disruption of X inactivation was associated to her severe phenotype.
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Pentasomy X (49,XXXXX) is a rare chromosome abnor-
mality, first described in a 2-year-old girl [1], with less
than 30 cases reported in the literature [2-30] and only
one in a patient of 15 years of age [25]. The characteristic
phenotype associated with a 49,XXXXX karyotype is more
severe than in X trisomies and tetrasomies [25,31], includ-
ing severe mental retardation with delayed speech devel-
opment, short stature, coarse facial features, osseous and
articular abnormalities, congenital heart defects and skel-
etal and limb abnormalities. The actual incidence of pen-
tasomy X is unknown but may be comparable to
49,XXXXY, occurring in 1/85,000 males [31].
In normal, 46,XX females, X chromosome inactivation is
usually random [32], consequently to which every X chro-
mosome may be inactivated in a given cell during early
development; once inactivated, this state is stably main-
tained and transmitted to all clonal descendants [33,34].
Lyon's hypothesis [32] postulated that in patients with X
chromosome polysomies, X chromosome inactivation
was expected to be random and only one X chromosome
would remain functionally active. However, in patients
with a 49,XXXXY chromosome constitution, the late rep-
licating X chromosomes showed different patterns of rep-
lication, suggesting that X inactivation was likely to be less
efficient than in 46,XX females, and accounting for the
presence of more than one active X chromosome in some
cells [35,36]. Furthermore, analysis of histone H4 acetyla-
tion in a group of patients with 49,XXXXX, 49,XXXXY,
48,XXXY and 47,XXX karyotypes showed alterations in
deacetylation of histone H4 once the inactive state was
established [37]. These alterations might have affected the
outcome in determining the number and the choice of
which X chromosomes were deacetylated, probably due to
the presence of more than one X chromosome undergoing
inactivation. These results suggested that supernumerary
X chromosomes might be associated to abnormal pheno-
types due to excess of X active regions or to increased asyn-
chronism of X chromosome replication, mainly in
patients with four or five X chromosomes.
In this paper, we analyzed the origin of an X chromosome
pentasomy in a patient (Figure 1) with a 49,XXXXX kary-
otype and the inactivation status of her X chromosomes.
This was carried out by analysing chromosome replication
in Budr-pulsed cultures, the methylation status of the
HUMANDREC region in the patient, her mother, and in X




Cytogenetic analysis, X chromosome replication and 
parental origin of X chromosomes
The proband showed a 49,XXXXX karyotype in all cells
without evidence of mosaicism (Figure 2). 5-bromodeox-
yuridine (BrdU)-pulsed cultures showed clear patterns of
asynchronic replication of the proband's X chromosomes
(Figure 3); in all cells one early replicating X chromosome
was identified, together with four late replicating X chro-
mosomes showing different replication patterns. Replica-
tion patterns were classified as "early replicating" (e), "late
replicating" (l) and "very late replicating" (vl) according
to Sarto [35]. The observed proportion of cells showing
different number of X replication patterns accounted for
31% with 1e/2l/2vl, 23% with 1e/3l/1vl, 17% with 1e/1l/
3vl, and 29% with 1e/4vl.
Molecular analysis of five X-linked polymorphic loci in
the proband and her mother (Table 1) allowed for the
unequivocal identification of the parental origin of the X
chromosomes in the proband who carried four maternal
X chromosomes and one paternal X chromosome; this
last one with a 173-108-199-206-141 (P) haplotype.
Preferential inactivation of X chromosomes
The methylation status of X chromosomes, assayed in the
HUMANDREC region of the human androgen receptor
gene (AR), showed a skewed pattern of inactivation in the
proband's mother because one AR allelic fragment of 173
bp was preferentially amplified with respect to the other
of 179 bp (Figure 4). Similar analysis in the proband
showed that two maternal AR alleles were amplified (173
and 179); the 173 allele showing a preferential amplifica-
tion with respect to allele 179, and lack of amplification
of the paternal 199 allele (Figure 5). These results indi-
cated (i) a preferential inactivation of maternal X chromo-
somes containing the 173 allele in the proband; (ii) the
possibility that her maternal chromosomes with the 179
allele might be incompletely inactivated, and (iii) an
active paternal X chromosome.
Inactivation of X chromosomes present in somatic cell 
hybrids
The segregation of the proband's X chromosomes in a
panel of 51 HPRT1+ cell hybrid lines was informative for
analysing the functional status of each individual X chro-
mosome. Cell hybrids cloned in the same Petri dish were
included only when they showed different molecular pat-
terns; this was considered evidence that clones were differ-
ent from one another. Conversely, when cell hybrids
cloned in the same Petri dish showed an identical molec-
ular pattern only one of them was included because we
could not prove that they were different from one
another. Table 2 lists the molecular patterns of 33 cell
hybrid lines. Human-specific amplification patterns werePage 2 of 13
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Frontal (A) and side (B) view of patient's faceigure 1
Frontal (A) and side (B) view of patient's face. Note flat profile, ocular hypertelorism, upslanting palpebral fissures, epi-
canthic folds, flat nasal bridge, low-set ears, retrognathism and micrognathia. (C) Hand arachnodactily with difficulty on supina-
tion of right arm. (D) X ray of patient's arms showing radioulnar synostosis in right arm.
Molecular Cytogenetics 2009, 2:20 http://www.molecularcytogenetics.org/content/2/1/20not observed with rodent DNA with any primer herein
tested under similar PCR conditions.
Analysis of cell hybrids allowed for the identification of
three maternal haplotypes: M1, with 185-112-173-202-
135 (in cell hybrids 1PXKB2, 1PXKB5, 1PXKF4, 1PXKH4,
1PXKI3, 1PXKL1, 1PXKN2); M2, with 163-104-179-204-
139 (in cell hybrids 1PXKG4, 1PXKH2, 1PXKJ6, 1PXKM1
and 1PXKR1), and MR, with 185-112-179-204-139 (in
cell hybrid 1PXKQ3). MR was a recombinant maternal
haplotype, derived from a crossover between DXS1068
and AR. The finding of cell hybrid lines with single M1,
M2 or P haplotypes, indicated that the HPRT1 locus of
donor origin was functionally active in different X chro-
mosomes of the proband.
To discriminate whether survival in HAT medium was
associated to presence of one (or more) active X chromo-
some(s) in cell hybrids showing any combination of two
or three haplotypes, DNA from cell hybrids was first
digested with methylation-sensitive enzymes and subse-
quently amplified with AR-C primers (see Table 3).
These results showed that in nine cell hybrids with M1-M2
haplotypes, the 173 allele was exclusively amplified in
seven cell lines. In one cell hybrid line (1PXKA1), both
maternal AR alleles (173 and 179) were amplified, show-
ing similar peaks and suggesting random inactivation,
while in another cell hybrid line (1PXKP3), the 179 allele
was exclusively amplified. In all five cell hybrids with the
M1-P haplotypes, the 173 maternal allele was exclusively
amplified, as was the 179 maternal allele in the two M2-P
cell hybrid lines. Similarly, the 179 maternal allele was
exclusively amplified in 1PXKQ3, a cell hybrid with a
recombinant maternal haplotype (MR) and a paternal (P)
haplotype. In ten other cell hybrid lines with the M1-M2-
P haplotypes, the observed pattern of amplification was
similar to the one observed in the proband's lymphocytes,
showing a large peak corresponding to allele 173, a
smaller peak corresponding to allele 179, and lack of
amplification of the 199 paternal allele.
Number of X chromosomes in selected cell hybrids
A comparison with FISH data showed that the number of
human X chromosomes retained in cell hybrids and the
number of X haplotypes were very frequently coincident
in a sample of eight cell hybrid lines in which all possible
haplotype combinations were observed Table 3; Figure 6).
This correspondence was also found in cell hybrid
1PXKJ6, in which a single haplotype and a single human
X chromosome were observed.
G-band karyotype of the patient showing 49,XXXXXFigure 2
G-band karyotype of the patient showing 49,XXXXX.
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Metaphase of BrdU-pulsed cultureFigure 3
Metaphase of BrdU-pulsed culture. Arrows point to X chromosomes showing different replication patterns: e = early; l = 






Table 1: Molecular analysis of five X-linked polymorphic loci
MARKERS AND LOCATION
AFM276 DXS1068 AR AFM150 AFM199
(Xp21) (Xp11.23) (Xq11.2-q12) (Xq25) (Xq28)
PROBAND (49,XXXXX) 163/185/173 104/112/108 173/179/199 202/204/206 135/139/141
MOTHER 163/185 104/112 173/179 202/204 135/139
Alelles are indicated by number of base pairs of amplified fragments. Paternal alleles of proband are shown in bold case.
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Sequence analysis of the minimal region of the XIST pro-
moter did not show C(- 43)A or C(- 43)G in the proband
and her mother, ruling out that alterations at this site
might be responsible for skewed X inactivation. Moreover,
mutational screening of the proband's X chromosomes in
10 cell hybrids confirmed that these mutations were not
present in her chromosomes. This was especially evident
in three of these cell hybrids (1PXKB5, 1PXKE3 and
1PXKG4), each which with a single X haplotype (M1, P
and M2 respectively).
Discussion
Here we report the second case of a 49,XXXXX karyotype
in a proband of 15 years of age [25] and the first one ana-
lyzed in detail for its X inactivation pattern. Analysis of
BrdU-pulsed cultures suggested that the functionally sta-
tus of the four allocyclic X chromosomes varied within
and between cells, probably resulting from disruption of
the kinetics of late DNA replication and accounting for the
a higher number of active X chromosome regions in the
49,XXXXX patient with respect to the single inactivated X
chromosome in a normal 46,XX female.
The molecular identification of four maternal X chromo-
somes in the proband indicated that this maternal X tetra-
somy originated by two consecutive non disjunctions
during oogenesis, in agreement with previous findings on
the maternal origin of X polysomies [20,21,29,38]. This
was in agreement with the subsequent identification, in
the cell hybrid panel, of three maternal haplotypes, two
presumably parental (M1 and M2) and one recombinant
(MR). Altogether, the proband carried four different
maternal X chromosomes; the fourth one corresponding
to the MR counterpart (with the 163-104-173-202-135
haplotype) that was not found in the cell hybrid panel.
A comparison of X inactivation patterns in the proband
showed that her paternal X chromosome was always
active and that her maternal X chromosomes carrying the
173 allele (with M1 and the 163-104-173-202-135 haplo-
types) were preferentially inactivated with respect to X
chromosomes with 179 allele (with M2 and MR haplo-
types). Interestingly, the smaller peak of the amplified
179 allele indicated that some X chromosomes containing
this allele had not been inactivated.
Analysis of cell hybrids confirmed these findings in 10 cell
hybrids with M1-M2-P haplotypes, while in seven cell
hybrids with M1-M2 haplotypes, 173 was the only ampli-
fied allele. However, it also showed that not all X chromo-
somes with the M1 haplotype were inactivated because (i)
M1 was shown to be the only haplotype in two cell
hybrids (1PXKB5 and 1PXKH4); (ii) in one M1-M2 cell
hybrid (1PXKP3), only the 179 allele was amplified, and
(iii) an apparent random inactivation was observed in
another M1-M2 cell hybrid (1PXKA1), indicated by an
equal amplification of 173 and 179 alleles (Table 3). Fur-
thermore, M2 was the only haplotype found in three cell
hybrids (1PXKG4, 1PXKJ6 and 1PXKR1; Table 2), indicat-
ing that their X chromosomes were functionally active.
HUMANDREC amplification of patient's mother DNA show-ing alleles 173 nd 179 (t p)Fi ur  4
HUMANDREC amplification of patient's mother DNA 
showing alleles 173 and 179 (top). Amplification follow-
ing digestion with methylation-sensitive endonucleases HhaI 
and HpaII (bottom) indicates preferential inactivation of the 
mother's X chromosome carrying the 173 allele.
HUMANDREC amplification of patient's DNA showing alleles 173, 179 and 199 (top)Figure 5
HUMANDREC amplification of patient's DNA show-
ing alleles 173, 179 and 199 (top). Amplification follow-
ing digestion with methylation-sensitive endonucleases HhaI 
and HpaII (bottom) indicates preferential inactivation of X 
chromosomes carrying the 173 allele and lack of amplifica-
tion of the 199 paternal allele.Page 6 of 13
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Hybrid cell Human X chromosome marker Haplotype(s)
AFM276 DXS1068 AR AFM150 AFM199
1PXKA1 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXK A3 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKB1 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKB2 185/173 112/108 173/199 202/206 135/141 M1-P
1PXKB4 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKB5 185 112 173 202 135 M1
1PXKC1 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKC2 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKE2 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKE3 173 108 199 206 141 P
1PXKE4 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKF1 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKF4 185/173 112/108 173/199 202/206 135/141 M1-P
1PXKG4 163 104 179 204 139 M2
1PXKH2 163/173 104/108 179/199 204/206 139/141 M2-P
1PXKH4 185 112 173 202 135 M1
1PXKI1 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKI3 185/173 112/108 173/199 202/206 135/141 M1-P
1PXKJ6 163 104 179 204 139 M2
1PXKL1 185/173 112/108 173/199 202/206 135/141 M1-P
1PXKL3 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKM1 163/173 104/108 179/199 204/206 139/141 M2-P
1PXKM3 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKN1 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKN2 185/173 112/108 173/199 202/206 135/141 M1-P
1PXKO1 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKP3 185/163 112/104 173/179 202/204 135/139 M1-M2Page 7 of 13
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types, inactivation patterns suggested that X chromo-
somes with the M2 haplotype were not completely
inactivated.
When counting the number of haplotypes associated to X
chromosome activity, demonstrated by positive selection
in HAT medium, there was a 100% correspondence
between the P haplotype and X chromosome activity in all
19 cell hybrids where this haplotype was identified. Con-
versely, the M1 haplotype, present in 25 cell hybrids, was
associated to X chromosome activity in only three cell
hybrids (12%), while the M2 haplotype, present in 23 cell
hybrids, was associated to activity in 10 cell hybrids
(43.5%). Finally, the MR haplotype was not found to be
associated with X chromosome activity in our cell hybrid
panel.
FISH analysis showed a reasonable correspondence
between number of different haplotypes and number of X
chromosomes in nine cell hybrid lines although this coin-
cidence did not prove that these X chromosomes were
originally present in the same human cells from which
each cell hybrid derived because cell fusion does not nec-
essarily take place between single human cells and single
rodent cells.
Conclusion
Our studies showed that, under the hypothesis of random
X inactivation, the theoretically expected five equal classes
of cells with one active X chromosome and four inactive X
chromosomes were unlikely to be present in the proband
because the paternal X chromosome was always active,
accounting for a 5-fold increase with respect to its
expected proportion (20%). Moreover, 12% of X chromo-
somes with the M1 haplotype were shown to be active,
while the maternal X chromosome with M2 haplotype
was active in 43.5% of cell hybrids, in more than twice the
expected proportion assuming random inactivation. It is
likely that the presence of five X chromosomes might dras-
tically affect the process of inactivation that was found to
require transient localization of X inactivation centres in
cell nuclei [39] and correct pairing between X chromo-
somes. Furthermore, we did not find alterations at the - 43
XIST minimal promoter [40,41] that might explain the
skewed inactivation pattern observed in the proband or
her mother which, however, did not rule out that muta-
tions might have occurred at other promoter regions.
Finally, the presence of five X chromosomes in the
proband must have represented a serious misbalance in
early stages of development before the time X inactivation
occurred. Moreover, this unusual high number of X chro-
mosomes must have subsequently impaired the process of
X dosage compensation, consequently to which more
than one X chromosome remained functionally active,
resulting in a functional X polysomy. These factors must
account for her severe physical phenotype and mental
retardation, probably aggravated by a parental imprinting
effect [42] resulting from active X chromosomes of the
same parental origin.
Proband and Methods
C.S.S is a 15 year old female whose mother was 17 years
of age at the time she was born. At birth, she weighted
1,200 g and her height was 39 cm. She was referred for
clinical investigation for multiple anomalies (congenital
heart defect, cleft soft palate, and facial dysmorphies) at 4
months of age. A recent physical examination showed a
mentally retarded young adult, with poor language devel-
opment, marfanoid habitus and disproportionate upper/
lower body segments (Figure 1); her profile was very flat;
with ocular hypertelorism, upslanting palpebral fissures,
epicanthic folds, flat nasal bridge, low-set ears, posterior
cleft palate, retrognathism, and micrognathia. A low pos-
terior hairline, left scoliosis, bilateral fifth finger clinodac-
tily, hand and feet arachnodactily, and difficulty on
supination of the right arm corresponding to a radioulnar
synostosis were present. A congenital heart defect (patent
ductus arteriosus and ventricular septal defect) was surgi-
1PXKQ2 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
1PXKQ3* 185/173 112/108 179/199 204/206 139/141 MR-P
1PXKR1 163 104 179 204 139 M2
1PXKR4 185/163 112/104 173/179 202/204 135/139 M1-M2
1PXKS1 185/163 112/104 173/179 202/204 202/204 M1-M2
1PXKS3 185/163/173 112/104/108 173/179/199 202/204/206 135/139/141 M1-M2-P
Paternal alleles are shown in bold case; * = cell hybrid with recombinant X haplotype (MR)
Table 2: Molecular patterns of 33 cell hybrid lines and X chromosome haplotypes (Continued)Page 8 of 13
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Table 3: X chromosome inactivation in cell hybrids with more than one X haplotype
Cell hybrid Haplotypes Number of X chromosomes AR alelles Amplified alelle(s)
1PXKA1 M1-M2 2 (92%), 1(8%) 173/179 173 = 179
1PXKA3 M1-M2-P 3 (75%), 2 (18%), 1 (7%) 173/179/199 173 > 179
1PXKB1 M1-M2 173/179 173
1PXKB2 M1-P 2 (88%), 1 (12%) 173/199 173
1PXKB4 M1-M2-P 173/179/199 173 > 179
1PXKC1 M1-M2 173/179 173
1PXKC2 M1-M2-P 173/179/199 173 > 179
1PXKE2 M1-M2 173/179 173
1PXKE4 M1-M2-P 173/179/199 173 > 179
1PXKF1 M1-M2 173/179 173
1PXKF4 M1-P 2 (85%), 1 (15%) 173/199 173
1PXKH2 M2-P 2 (86%), 1 (14%) 179/199 179
1PXKI1 M1-M2-P 173/179/199 173 > 179
1PXKI3 M1-P 173/199 173
1PXKL1 M1-P 173/199 173
1PXKL3 M1-M2-P 173/179/199 173 > 179
1PXKM1 M2-P 2 (89%), 1 (11%) 179/199 179
1PXKM3 M1-M2-P 173/179/199 173 > 179
1PXKN1 M1-M2 173/179 173
1PXKN2 M1-P 173/199 173
1PXKO1 M1-M2-P 173/179/199 173 > 179
1PXKP3 M1-M2 173/179 179
1PXKQ2 M1-M2-P 173/179/199 173 > 179
1PXKQ3* MR-P 2 (84%), 1 (16%) 179/199 179
1PXKR4 M1-M2 173/179 173
1PXKS1 M1-M2 173/179 173
1PXKS3 M1-M2-P 3 (78%), 2 (14%), 1 (8%) 173/179/199 173 > 179
Paternal alleles are shown in bold case. Number of X chromosomes was estimated by FISH
Molecular Cytogenetics 2009, 2:20 http://www.molecularcytogenetics.org/content/2/1/20cally repaired at the first year of life. A low count of dermal
ridges was also present.
Cytogenetic analyses were carried out at 4 months and at
15 years of age using standard lymphocyte cultures and
BrdU-pulsed cultures [43]. Chromosome preparations
were identified by conventional GTG banding [44] at the
500 band level in 100 cells. Chromosome preparations of
BrdU-pulsed cultures were stained [45], and X replication
patterns identified in 100 cells and classified according to
Sarto's criteria [35].
Cell Fusion protocols
Hprt - cell lines of rodent origin were used as recipient cell
lines in fusion experiments with human lymphocytes of
the proband isolated with Ficoll® (Sigma, St Louis). A cell
A-B: Chromosome painting of a metaphase of the patient showing presence of five X chromosomesFigure 6
A-B: Chromosome painting of a metaphase of the patient showing presence of five X chromosomes. C-D: 
Chromosome painting of a metaphase of cell hybrid 1PXKH2 showing two human X chromosomes. E-F: Chromosome paint-
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from Akodon cursor [46]. Following a seven day growth in
DMEM/6MP selective medium (Dulbecco's Minimal
Essential Medium supplemented with 10% FCS and 6-
mercaptopurine 16.7 μg/ml), 3 × 106 recipient cells were
fused with 1.2 × 107 human lymphocytes [47]. Cell
hybrids were selected in DMEM/HAT medium [DMEM
with 10% FCS, hypoxanthine (100 μM), aminopterin (0.4
μM), thymidine (16 μM)].
Cell death was monitored periodically; after a 2-3 weeks
period, visible colonies were cloned inside Penicillinders,
transferred to individual dishes and expanded to culture
flasks. A maximum of three colonies was cloned from
each Petri dish. Each dish was identified by a letter and
each colony by a number. Controls were carried out for
demonstrating adverse selection of recipient cells; aliq-
uots of the same AKO1/15 cells used in fusion experi-
ments were grown in DMEM/HAT medium.
DNA isolation and PCR amplifications of X linked 
polymorphic markers
DNA was extracted from blood samples of the proband,
her mother, the recipient cell line AKO1/15, and cell
hybrid lines. DNA isolation was carried out by standard
procedures [48].
PCR amplifications of four human, X-linked microsatel-
lite loci were carried out with DNA samples of the
proband, her mother, 51 cell hybrid lines, and the rodent
cell line. PCR reactions contained 100 ng of DNA, reac-
tion buffer [16 mM (NH4)2SO4, 67 mM Tris-HCl (pH =
8.8), 0.01% Tween-20, 2.5 mM MgCl2], 0.1 mM each
dNTP, 5 pM of each primer and 0.6 U Taq polymerase
(Pharmacia) in a final volume of 15 μl. All microsatellite
forward-primers were 5'-labelled with FAM fluorochrome
(Perkin-Elmer). Cycling conditions included an initial
denaturation at 94°C for 5 min and pairing at 65°C for 5
min, followed by 30 cycles at 94°C for 45 sec; 60°C with
primer pairs DXS1068.PCR1 and AFM150xf10 (or 65°C
with primer pairs AFM276xf5 and AFM199wc7) for 45
sec; 72°C for 45 sec, and a final extension period of 20
min at 72°C.
Amplified products were run in a MEGABACE 1000 auto-
matic DNA sequencer with 10× LPA buffer and Mega-
BACE™ Long Read Matrix with the GT Dye set 2 ET-ROX,
FAM (Applied Biosystems) and analyzed with Genetic
Profiler® v.2.0 (Amersham, 2002).
Analysis of X chromosome inactivation patterns
X-inactivation patterns were analyzed in the proband, her
mother and in 35 cell hybrid lines previously shown to
contain two or more X-chromosome haplotypes. The
methylation status of the X chromosome was assayed in a
region of the human androgen receptor (AR) gene located
in Xq11-q12. This AR region corresponded to nucleotides
451-661 of the HUMANDREC sequence [49] (GenBank
M20132), containing restriction sites for the methylation-
sensitive endonucleases HhaI and HpaII and a highly pol-
ymorphic VNTR. Polymorphisms were initially detected
in undigested genomic DNA samples with a 5' FAM-
labelled, forward AR-C primer, under specific PCR condi-
tions [50]. X chromosome methylation was assayed by
separate digestions of genomic DNA with excess of HhaI
and HpaII in final volumes of 22.5 μl at 37°C for 18
hours. Digestion products were subsequently used in PCR
reactions, under identical conditions with those used for
detecting VNTR polymorphisms. All PCR products were
analyzed with Genetic Profiler®, version 2.0.
Fluorescence in situ hybridization (FISH)
The X pentasomy was also demonstrated by FISH with an
X whole chromosome probe. The number of X chromo-
somes present in cell hybrid lines 1PXKA1, 1PXKA3,
1PXKB2, 1PXKF4, 1PXKH2, 1PXKJ6, 1PXKM1, 1PXKQ3
and 1PXKS3 was estimated in 100 cells per cell line. In all
cell hybrid lines (except for 1PXKJ6), more than one X
haplotype was identified, which were present in different
combinations (M1-M2, M1-P, M2-P, MR-P and M1-M2-
P).
We used a human specific, X chromosome probe (WCPX)
provided by Roscoe Stanyon (Frederick Cancer Research
Facility, NCI, NIH), which was amplified and labelled by
random priming with the 6MW primer 5'-CCG ACT CGA
GNN NNN NAT GTG G-3' (N = any base). Reactions were
carried out with 150 ng of probe DNA, 20 pmol of primer,
5 μl of 10× reaction buffer (245 mM TAPs, 500 mM KCl,
20 mM MgCl2, 2 mM dithiothreitol; pH = 9.3); 0.5 mM
dCTP, dATP, dGTP, 0.25 mM dTTP; 5 μl of W-1 detergent
(stock solution = 100 μl of W-1 in 10 ml of distilled
water), 2 nM FITC-12-dUTP (Roche), and 3 U of Taq Plat-
inum® (Invitrogen), in final volumes of 50 μL. Cycling
conditions consisted of an initial denaturation at 94°C for
3 min followed by 35 cycles at 94°C for 1 min, a 62°C for
1 min, 72°C for 1 min, and a final extension period at
72°C for 9 min.
Slides were denatured in 70% formamide/2× SSC (pH =
7.0) at 73°C for 5 min and dehydrated in 70%, 85% and
100% ethanol and allowed to dry at room temperature.
Probe preparation, incubation with slides and further
processing were carried out according to Vysis® standard
protocols for hybridization with whole chromosome
probes. Preparations were analyzed with epifluorescence
microscopes (Olympus DX-60 and DX-50). Images were
captured with QUIPS - PathVysion (Vysis®) and Applied
Imaging.Page 11 of 13
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Analysis of a 380 pb minimal region of the XIST promoter
was carried for characterising position - 43 with respect to
the possibility of finding C(- 43)A or C(- 43)G in the
proband, her mother and in ten cell cell hybrid lines
derived from the proband (1PXKA1, 1PXKB1, 1PXKB2,
1PXKB5, 1PXKC1, 1PXKE3, 1PXKG4, 1PXKJ6, 1PXKP3,
1PXKQ2). DNA was amplified with a forward primer 5'-
TGAGAACTGGAAAACCCATTG-3' and a reverse primer
5'-ATACGCCATAAAGGGTGTTGG-3'. Reactions were car-
ried out with 200 ng of DNA, 25 pmol of each primer, 0.2
mM of each dNTP and 0.2 U of Taq Platinum® (Invitro-
gen), with 1× enzyme buffer and 1.5 mM MgCl2, in a final
volumes of 50 μL. Cycling conditions included an initial
denaturation step at 94°C for 5 min, followed by 35
cycles at 94°C for 45 sec, 55°C for 45 sec, and 72°C for
45 sec, with a final extension period at 72°C for 15 min in
a GeneAmp PCR System 2400 (Applied Biosystems).
Amplified products were purified with GFX PCR DNA and
Gel Band Purification Kit (GE Healthcare) and eluted in
50 μL of water. Approximately 100 ng of the purified frac-
tion was labelled with 5 pmol of either primer according
to the conditions outlined by the DYEnamic ET Dye Ter-
minator Cycle Sequencing Kit for MegaBace DNA Analysis
Systems (GE Healthcare). Sequencing was carried out in a
MEGABACE 1000 automatic DNA sequencer. Sequences
were aligned manually with Chromas version 1.45 [51]
and MEGA 4.0 [52].
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